Valuation: CellaVision AB

Market Cap 4.48B 454M 407M 375M 340M 635M 43.27B 646M 1.79B 22.64B 1.71B 1.67B 71.72B P/E 2026 *
32.3x
P/E 2027 * 25x
Enterprise Value 4.29B 435M 390M 360M 325M 608M 41.44B 618M 1.71B 21.69B 1.63B 1.6B 68.69B EV / Sales 2026 *
5.49x
EV / Sales 2027 * 4.83x
Free-Float
81.06%
Yield 2026 *
1.46%
Yield 2027 * 1.72%
1 day+5.32%
1 week+13.82%
Current month+8.43%
1 month+8.81%
3 months+30.06%
6 months+48.58%
Current year+19.47%
1 week 167.6
Extreme 167.6
188
1 month 160.6
Extreme 160.6
188
Current year 117.6
Extreme 117.6
188
1 year 117.6
Extreme 117.6
191.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
419
10 years 75.25
Extreme 75.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 Buy

Chief Executive Officer

8,077 0.0339%
9/2/26 Free 100,000 0.4193%
4/28/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
+7.44%+13.82%+2.40%+46.03% 420M
+0.71%+4.82%+27.02%+63.36% 260B
+1.24%+3.15%+10.73%+28.03% 165B
+1.03%+1.11%-16.52%+73.61% 154B
+0.61%-7.22%-57.44%-14.71% 61.49B
+2.90%+4.83%+14.21%+51.44% 52.9B
+0.70%+2.83%-12.22%-6.48% 52.84B
-2.35%-3.79%+8.26%+63.10% 51.46B
-0.18%+4.18%+26.50%+79.06% 51.16B
+0.67%+5.37%+39.77%+102.82% 46.85B
Average +0.88%+1.80%+4.27%+48.63% 89.61B
Weighted average by Cap. +0.39%+1.41%+7.23%+51.39%

Financials

2026 *2027 *
Net sales 782M 79.27M 71M 65.51M 59.28M 111M 7.55B 113M 312M 3.95B 297M 291M 12.51B 879M 89.15M 79.85M 73.67M 66.66M 125M 8.49B 127M 351M 4.44B 335M 327M 14.07B
Net income 139M 14.07M 12.6M 11.63M 10.52M 19.68M 1.34B 20M 55.35M 701M 52.81M 51.69M 2.22B 181M 18.4M 16.48M 15.21M 13.76M 25.73M 1.75B 26.15M 72.37M 917M 69.06M 67.59M 2.9B
Net Debt -189M -19.22M -17.22M -15.88M -14.37M -26.88M -1.83B -27.31M -75.6M -958M -72.14M -70.6M -3.03B -230M -23.33M -20.9M -19.28M -17.45M -32.62M -2.22B -33.15M -91.76M -1.16B -87.55M -85.69M -3.68B
Projected Income Statement - Annual - CellaVision AB
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
26-10-29 SEK 187.80 +7.44% 461,715
26-10-28 SEK 174.80 +2.34% 38,139
26-10-27 SEK 170.80 -0.12% 24,387
26-10-26 SEK 171.00 +0.71% 25,189
26-10-23 SEK 169.80 -0.12% 27,745
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
187.80SEK
Average target price
181.67SEK
Spread / Average Target
-3.27%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CellaVision AB
  1. Stock Market
  2. Stocks
  3. CEVI Stock